Ampliconsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-03-14
Share capital
20 000,00 PLN
Activity description

Amplicon is a biotechnology company that specializes in developing diagnostic tests based on real-time PCR technology, utilizing data from DNA sequences. They provide precise and reliable diagnostic tests for infectious and genetic diseases in both humans and animals, and they also design, optimize, and validate molecular diagnostic assays. Additionally, they conduct a range of highly specialized molecular research studies.

Registered address
ul. Klecińska 125, 54-413 Wrocław, Poland
Website
amplicon.plWebsite active
Email
Email address current
Phone
Electronic delivery address
AE:PL-17762-91725-JSDFD-17

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 48.33kMedianUSD 782.27kAverageUSD 24.03m
Net profit
This companyUSD -54.32kMedianUSD 7.91kAverageUSD 2.59m
Operating costs
This companyUSD 102.19kMedianUSD 723.93kAverageUSD 19.92m
Assets
This companyUSD 69.63kMedianUSD 800.34kAverageUSD 29.11m

Bank accounts

Registered as a VAT taxpayer on 2014-05-01. Active

  • mBank
    34 1140 2004 0000 3102 7510 2857

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

13 public aid cases recorded, with a total value of $92,844.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$122
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$296
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$243

European Funds

ProjectEU co-financing
Opracowanie i walidacja panelowego testu diagnostycznego do oceny ryzyka zapadnięcia na chorobę otępienną i wdrożenia spersonalizowanej metody terapii farmakologicznej oraz algorytmu do interpretacji wyników
$174.9K

Tenders

6 tenders recorded as contractor, with a total value of $72,894.

SubjectAmount
Testy diagnostyczne II
$968
Testy diagnostyczne III
$2,234
Testy diagnostyczne I
$10,663

Public sector contracts

Amplicon is the contractor in 3 public sector contracts, worth PLN 42.36k in total. They were signed with 2 public buyers.

Public buyerValue
Wojewódzki Inspektorat Weterynarii w GdańskuPLN 8,000
Inspekcja Weterynaryjna Wojewódzki Inspektorat Weterynarii w SzczeciniePLN 26,500
Wojewódzki Inspektorat Weterynarii w GdańskuPLN 7,855

Authorized Representatives

Janusz Krzysztof Piechota – President of the Management Board
Małgorzata Piskozub – Vice President of the Management Board

Manner of representation

In the case of a multi-member management board: the members of the management board act independently.

Ownership

OwnerSharesShare valueStake
Janusz Krzysztof Piechota (49)
10$2,701.2450%
Małgorzata Piskozub (44)
10$2,701.2450%

Beneficial owners

Person

Competitors

Name
F1 PharmaS.A.
Ti-Comsp. z o.o.
Pexon Polandsp. z o.o.

Change history

DateEvent
2019-06-05PKD change
2019-03-22Address change
2014-03-14Entered in the register

FAQ

Last updated: 2026-10-07